Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Metastatic Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06566755
What this trial is testing

Cadonilimab (AK104) Combined With Chemotherapy and Bevacizumab as First-line Treatment for RAS Mutated or Right Sided-metastatic MSS Colorectal Cancer

Who this might be right for
Colorectal Cancer
Caigang Liu 30
Large-scale testing (Phase 3)Looking for participantsNCT07284849
What this trial is testing

Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Who this might be right for
CRC (Colorectal Cancer)
Incyte Corporation 700
Testing effectiveness (Phase 2)Study completedNCT00967616
What this trial is testing

Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy

Who this might be right for
Colorectal CancerNeoplasms, Colorectal
Daiichi Sankyo 100
Not applicableStudy completedNCT03043950
What this trial is testing

Validation of a New Prognostic Score for Adult Patients With RAS Wild-type mCRC Treated With Vectibix® and FOLFIRI or FOLFOX in First Line (VALIDATE)

Who this might be right for
Metastatic Colorectal CancerRAS Wild-type
iOMEDICO AG 647
Large-scale testing (Phase 3)UnknownNCT04509635
What this trial is testing

Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis

Who this might be right for
Colorectal CancerLiver MetastasesCetuximab
Fudan University 50
Testing effectiveness (Phase 2)Study completedNCT00508404
What this trial is testing

Panitumumab Plus FOLFIRI in First-line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Amgen 154
Testing effectiveness (Phase 2)Study completedNCT00904839
What this trial is testing

BIBF 1120 Versus Bevacizumab in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Boehringer Ingelheim 128
Testing effectiveness (Phase 2)Study completedNCT04425239
What this trial is testing

Intermittent or Continuous Panitumumab Plus FOLFIRI for RAS/B-RAF Wild-type Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Stage IV
National Cancer Institute, Naples 151
Testing effectiveness (Phase 2)Study completedNCT00080951
What this trial is testing

Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 14
Large-scale testing (Phase 3)Looking for participantsNCT06662786
What this trial is testing

Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Janssen Research & Development, LLC 1,000
Testing effectiveness (Phase 2)UnknownNCT04097444
What this trial is testing

CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC

Who this might be right for
Metastatic Colorectal Cancer
Chugai Pharmaceutical 112
Not applicableStudy completedNCT02322736
What this trial is testing

Prospective Observational Study of 1st and 2nd Line Vectibix® Use in RAS-wt mCRC Pts to Evaluate Pattern of Use and ORR

Who this might be right for
Metastatic Colorectal Cancer
Amgen 218
Large-scale testing (Phase 3)Study completedNCT02484833
What this trial is testing

Erbitux MEtastatic Colorectal Cancer Strategy Study

Who this might be right for
Antineoplastic Agents
Armando Orlandi 607
Testing effectiveness (Phase 2)UnknownNCT04160416
What this trial is testing

MXELOXIRI Combined With Molecular Targeted Drug in mCRC

Who this might be right for
Unresectable Metastatic Colorectal Cancer
First Affiliated Hospital of Zhejiang University 48
Not applicableUnknownNCT03401957
What this trial is testing

The Emergence of RAS Mutations in Metastatic Colorectal Cancer Patients Receiving Cetuximab Treatment

Who this might be right for
Colorectal CancerDrug ResistanceMass Spectrometry+1 more
National Health Research Institutes, Taiwan 120
Testing effectiveness (Phase 2)Study completedNCT01135498
What this trial is testing

Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 90
Testing effectiveness (Phase 2)UnknownNCT04984369
What this trial is testing

The Efficacy of HLX208 (BRAF V600E Inhibitor) With Cetuximab for Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation After First-line Treatment

Who this might be right for
CRC
Shanghai Henlius Biotech 50
Testing effectiveness (Phase 2)Looking for participantsNCT07257653
What this trial is testing

The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line Treatment of RAS/BRAF Wild Type Unresectable Metastatic Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsRASBRAF+2 more
Zhejiang University 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07070713
What this trial is testing

Efficacy and Safety of FOLFOX+Cetuximab vs. FOLFOXIRI+Bevacizumab Both With QL1706 in First-Line Treatment of Left-Sided mCRC

Who this might be right for
Metastatic Colorectal Cancer With Left-sided Primary TumorImmunotherapy
Fujian Cancer Hospital 44
Post-approval studies (Phase 4)UnknownNCT01315990
What this trial is testing

FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular Exanthema

Who this might be right for
Colorectal Cancer Metastatic
Dr. Carl Schimanski 165
Next Page